Ahmed I, Cronin P S, Abou Neel E A, Parsons A J, Knowles J C, Rudd C D
Division of Materials, Faculty of Engineering, University of Nottingham, Nottingham, United Kingdom.
J Biomed Mater Res B Appl Biomater. 2009 Apr;89(1):18-27. doi: 10.1002/jbm.b.31182.
Polymers prepared from polylactic acid (PLA) have found a multitude of uses as medical devices. The main advantage of having a material that degrades is so that an implant would not necessitate a second surgical event for removal. In addition, the biodegradation may offer other advantages. In this study, fibers produced from a quaternary phosphate-based glass (PBG) in the system 50P(2)O(5)-40CaO-5Na(2)O-5Fe(2)O(3) (nontreated and heat-treated) were used to reinforce the biodegradable polymer, PLA. Fiber properties were investigated, along with the mechanical and degradation properties and cytocompatibility of the composites produced. Retention of mechanical properties overtime was also evaluated. The mean fiber strength for the phosphate glass fibers was 456 MPa with a modulus value of 51.5 GPa. Weibull analysis revealed a shape and scale parameter value of 3.37 and 508, respectively. The flexural strength of the composites matched that for cortical bone; however, the modulus values were lower than those required for cortical bone. After 6 weeks of degradation in deionized water, 50% of the strength values obtained was maintained. The composite degradation properties revealed a 14% mass loss for the nontreated and a 10% mass loss for the heat-treated fiber composites. It was also seen that by heat-treating the fibers, chemical and physical degradation occurred much slower. The pH profiles also revealed that nontreated fibers degraded quicker, thus correlating well with the degradation profiles. The in vitro cell culture experiments revealed both PLA (alone) and the heat-treated fiber composites maintained higher cell viability as compared to the nontreated fiber composites. This was attributed to the slower degradation release profiles of the heat-treated composites as compared to the nontreated fiber composites. SEM analyses revealed a porous structure after degradation, and it is clear that there are possibilities here to tailor the distribution of porosity within polymer matrices.
由聚乳酸(PLA)制备的聚合物已在医疗设备领域有多种用途。使用可降解材料的主要优势在于植入物无需二次手术取出。此外,生物降解可能还有其他优势。在本研究中,采用系统50P₂O₅ - 40CaO - 5Na₂O - 5Fe₂O₃中基于季磷酸盐的玻璃(PBG,未处理和热处理)制成的纤维来增强可生物降解聚合物PLA。研究了纤维性能以及所制备复合材料的力学性能、降解性能和细胞相容性。还评估了力学性能随时间的保持情况。磷酸盐玻璃纤维的平均纤维强度为456 MPa,模量值为51.5 GPa。威布尔分析显示形状参数和尺度参数值分别为3.37和508。复合材料的弯曲强度与皮质骨相当;然而,模量值低于皮质骨所需的值。在去离子水中降解6周后,所获得强度值的50%得以保持。复合材料的降解性能显示,未处理的纤维复合材料质量损失14%,热处理的纤维复合材料质量损失10%。还发现通过对纤维进行热处理,化学和物理降解发生得慢得多。pH曲线也显示未处理的纤维降解更快,因此与降解曲线相关性良好。体外细胞培养实验表明,与未处理的纤维复合材料相比,PLA(单独)和热处理的纤维复合材料均保持较高的细胞活力。这归因于与未处理的纤维复合材料相比,热处理复合材料的降解释放曲线较慢。扫描电子显微镜分析显示降解后有多孔结构,显然在此有可能调整聚合物基质内孔隙率的分布。